Owner Baxter Healthcare S.A.

Inventors Blake, Milan S; Long-Rowe, Karen O

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004201101

Parent 60495

Filing date 16 March 2004

Wipo publication date 8 April 2004

C12N 001/06 Micro-organisms, e.g. protozoa - Lysis of micro-organisms

C07K 001/00 General processes for the preparation of peptides

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A01N 043/04 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 038/00 Medicinal preparations containing peptides

A61K 039/116 Medicinal preparations containing antigens or antibodies - Polyvalent bacterial antigens

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 039/09 Medicinal preparations containing antigens or antibodies - Streptococcus

A61K 039/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 039/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

C12P 021/04 Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12N 015/00 Mutation or genetic engineering

C12N 001/12 Micro-organisms, e.g. protozoa - Unicellular algae